MULTIPLE SCLEROSIS THERAPEUTICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Multiple Sclerosis Therapeutics -Overview The global multiple sclerosis therapeutics market was valued at US$ 19,653.7 million in 2016 and is further estimated to exhibit a decent CAGR of 2.5% over the forecast period (2017-2025). The proposed launch of potential pipeline candidates, the presence of potential regional markets, and increasing government initiatives aimed at eliminating the disease in Asia Pacific, Latin America, the Middle East, and Africa, are some of the indispensable factors fostering the growth of the global multiple sclerosis therapeutics market. The key market players have been concentrating on drug discovery to strengthen their drug development processes and accelerate the delivery of new treatments to patients living with the condition, thus augmenting the multiple sclerosis therapeutics market in the foreseeable period. For instance, in 2017, TG Therapeutics, Inc., signed an agreement with the U.S. Food and Drug Administration (FDA) regarding the Special Protocol Assessment (SPA) of the phase 3 clinical trials for TG-1101, which is an anti-D20 monoclonal antibody intended = for the treatment of relapsing forms of multiple sclerosis. Furthermore, in 2017, Antisense Therapeutics announced the proceeding of its Phase 2b clinical trials as the U.S. FDA lifted the clinical hold for the drug candidate ATL1102. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/multiple-sclerosis-therapeutics-market-1310 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION In 2011, Sanofi SA acquired Genzyme for a sum of US$ 20.1 billion and further acquired the rights for Genzyme’s injectable drug Lemtrada which was FDA approved in 2014 for the treatment of relapsing remitting multiple sclerosis. In 2015, Actelion Ltd., initiated Phase III development with ponesimod, which is a selective S1P1 receptor modulators in patients suffering from relapsing multiple sclerosis. Actelion Ltd. was acquired by Johnson & Johnson in 2017, gaining access to the pipeline drug candidate, thus expanding product portfolio. In 2017, Sanofi SA joined forces with Principia Biopharma, Inc., for the development of potential multiple sclerosis oral drug candidate PRN2246, which is a tyrosine kinase inhibitor currently undergoing clinical development. In 2014, Accelerated Cure Project for MS, Feinstein Kean Healthcare and Complex Adaptive Systems at Arizona State University came together to create iConquerMS. The introduction of new, efficient and promising B-cell targeted therapies acts as a vital growth factor for the global multiple sclerosis therapeutics market. For instance, in 2017, the FDA approved Genentech’s Ocrevus (ocrelizumab) a humanized monoclonal antibody targeting B-cells with CD20 molecule. Request a Sample copy of this reports https://www.coherentmarketinsights.com/insight/request-sample/1310 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION •Based on drug class, the corticosteroids segment leads the global market owing to the multiple advantages offered by these drugs, such as lower risk of side effects and higher number of drug candidates in the pipeline. •On the basis of route of administration, the injectables segment dominates the global market, owing to the higher recommendations of the doctors as the drugs administered by this route have instant mode of action. In November 2019, Qualicaps, Inc. presented its products and service offerings for the hard-capsule dosage form at the CPHI WORLDWIDE 2019 conference. In February 2018, CapsCanada Corporation announced the addition of a new, stateof-the-art, dedicated hydroxypropyl methylcellulose (HPMC) capsule manufacturing facility. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1310
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved